Long-term data on entecavir treatment for treatment-naive or lamivudine-resistant chronic hepatitis B infection in kidney transplant recipients.

Desmond Yat-Hin YapColin TangJames Y Y FungWai-Kay SetoMaggie K M MaBo Ying ChoyTak Mao Chan

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)

ETV showed favorable long-term efficacy and tolerability in treatment-naïve KTRs. One-third of lamivudine-resistant subjects showed non-response or viral breakthrough after ETV treatment.

Keyphrases

acute lymphoblastic leukemia
randomized controlled trial
machine learning
hepatitis b virus
combination therapy
hiv infected patients
electronic health record
study protocol